Ledger.Open graph →

SEC Form D · filed February 2, 2024

Stingray Therapeutics, Inc

Offering

$450K

Sold

$437K

Exemption

Rule 506(b)

Industry

Biotechnology

Location

DALLAS, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Sunil P. Sharma · Dallas, TXExec · Director Jonathan P. Northrup · Dallas, TXExec · Director Uma P. Bhatt · Dallas, TXExec · Director Uma P. Bhatt · Dallas, TXExec · Director Jonathan P. Northrup · Dallas, TXExec · Director Sunil P. Sharma · Dallas, TXExec · Director Daria Kuksenko · Boston, MAExec · Director Richard Yoken · White Plains, NYExec · Director Lawrence Bartimer · White Plains, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗